MOOGENE MEDI CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,900 KRW | +1.12% |
|
-6.40% | -31.28% |
More news
| 1 day | +1.12% | ||
| 1 week | -6.40% | ||
| Current month | -11.63% | ||
| 1 month | -25.20% | ||
| 3 months | -22.92% | ||
| 6 months | -31.03% | ||
| Current year | -31.28% |
1 week
1 485.00
2 090.00
1 month
1 485.002 690.00
Current year
1 485.003 385.00
1 year
1 485.003 790.00
3 years
1 485.006 190.00
5 years
1 485.007 790.00
10 years
1 485.007 790.00
| Managers | Title | Age | Since |
|---|---|---|---|
Tae-Jong Yoon
CEO | Chief Executive Officer | 50 | - |
Ji-Hoon Park
BRD | Director/Board Member | 48 | - |
Young-Seok Cho
BRD | Director/Board Member | 56 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Tae-Jong Yoon
CEO | Chief Executive Officer | 50 | - |
Young-Seok Cho
BRD | Director/Board Member | 56 | - |
Ji-Hoon Park
BRD | Director/Board Member | 48 | - |
Moogene medi Co Ltd is a Korea-based company mainly engaged in the research and development of biological and chemical agents capable of treating incurable diseases. The Company mainly manufactures and sells medicines such as treatments of colorectal cancer, treatments for hair loss, and treatments for diabetes.
Calendar
24/06/2024
- Investor Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -31.28% | 13.62M | |
| +34.25% | 51.07B | |
| -7.98% | 38.78B | |
| +35.88% | 38.61B | |
| -10.62% | 27.32B | |
| +11.87% | 26.35B | |
| -18.73% | 19.46B | |
| +40.59% | 13.58B | |
| +29.20% | 12.46B | |
| -4.06% | 11.75B |
- Stock Market
- Equities
- A322970 Stock
